Actinium Pharmaceuticals, Inc.
ATNM
Last
$1.07
Day
-0.9%
1y
-28.0%
5y
-87.2%
52w
-37.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
1.14
EMA 50
1.10
EMA 200
1.17
20d high
-23.9%
5y high
-92.9%
5y range
2th
Positions held
Your positionsATNM isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-1
Hold
watch
Signal
Neutral
Target
$1.20
Stop
$0.98
Stop distance
8.4%
Target vs last
+12.2%
Fundamentals
| Market cap | $33.96M | Enterprise value | -$1.18M | Trailing P/E | 3.00 | Forward P/E | -2.06 |
| PEG | — | Price / book | 1.12 | Beta | 0.27 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 100.0% | Operating margin | 78.8% |
| Profit margin | 32.2% | ROE | 45.9% | ROA | 11.6% | Debt / equity | 0.04 |
| Current ratio | 4.08 | Free cash flow | $7.14M | Analyst recommendation | none | Mean target | $3.60 |
| 52w high | $1.74 | 52w low | $0.74 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $35.0M | $0.0M | $0.0M | $0.1M | $0.0M | — |
| Op margin | 78.8% | — | — | -6324.4% | — | — |
| Net income | $27.9M | -$5.5M | -$5.9M | -$5.1M | -$6.9M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | $27.6M | -$5.9M | -$6.4M | -$5.7M | -$7.5M | — |
- Operating margin expanded to 78.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $0.0M | $0.1M | $1.0M | — |
| Op margin | -40274.4% | — | -64098.8% | -3311.1% | — |
| Net income | -$33.9M | -$38.2M | -$48.8M | -$33.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$36.2M | -$42.1M | -$51.9M | -$34.1M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsATNM · daily-10.0% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin